• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钌(II)多吡啶配合物作为含腈基和芳杂环的生物活性化合物的光解笼。

Ru(ii) polypyridyl complexes as photocages for bioactive compounds containing nitriles and aromatic heterocycles.

机构信息

Department of Chemistry, Wayne State University, 5101 Cass Ave, Detroit, Michigan 48202, USA.

出版信息

Chem Commun (Camb). 2018 Feb 1;54(11):1280-1290. doi: 10.1039/c7cc09000e.

DOI:10.1039/c7cc09000e
PMID:29323683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5904840/
Abstract

Photocaging allows for precise spatiotemporal control over the release of biologically active compounds with light. Most photocaged molecules employ organic photolabile protecting groups; however, biologically active compounds often contain functionalities such as nitriles and aromatic heterocycles that cannot be caged with organic groups. Despite their prevalence, only a few studies have reported successful caging of nitriles and aromatic heterocycles. Recently, Ru(ii)-based photocaging has emerged as a powerful method for the release of bioactive molecules containing these functional groups, in many cases providing high levels of spatial and temporal control over biological activity. This Feature Article discusses recent developments in applying Ru(ii)-based photocaging towards biological problems. Our groups designed and synthesized Ru(ii)-based platforms for the photoinduced delivery of cysteine protease and cytochrome P450 inhibitors in order to achieve selective control over enzyme inhibition. We also reported Ru(ii) photocaging groups derived from higher-denticity ancillary ligands that possess photophysical and photochemical properties distinct from more traditional Ru(ii)-based caging groups. In addition, for the first time, we are able to rapidly synthesize and screen Ru(ii) polypyridyl complexes that elicit desired properties by solid-phase synthesis. Finally, our work also defined steric and orbital mixing effects that are important factors in controlling photoinduced ligand exchange.

摘要

光笼技术允许通过光精确地控制生物活性化合物的释放,具有时间和空间的可控性。大多数光笼分子采用有机光不稳定保护基团;然而,生物活性化合物通常包含腈和芳香杂环等功能基团,这些基团不能用有机基团来笼蔽。尽管它们很常见,但只有少数研究报告了成功地对腈和芳香杂环进行笼蔽。最近,基于 Ru(ii)的光笼技术已成为一种强大的方法,可用于释放含有这些官能团的生物活性分子,在许多情况下可以对生物活性进行高度的时空控制。本文讨论了最近将基于 Ru(ii)的光笼技术应用于生物学问题的研究进展。我们的研究小组设计并合成了基于 Ru(ii)的平台,用于光诱导递送来实现对胱氨酸蛋白酶和细胞色素 P450 抑制剂的选择性控制。我们还报道了源自高齿配体的 Ru(ii)光笼基团,它们具有与更传统的基于 Ru(ii)的光笼基团不同的光物理和光化学性质。此外,我们首次能够通过固相合成快速合成和筛选出具有所需性质的 Ru(ii)多吡啶配合物。最后,我们的工作还定义了空间位阻和轨道混合效应,这是控制光诱导配体交换的重要因素。

相似文献

1
Ru(ii) polypyridyl complexes as photocages for bioactive compounds containing nitriles and aromatic heterocycles.钌(II)多吡啶配合物作为含腈基和芳杂环的生物活性化合物的光解笼。
Chem Commun (Camb). 2018 Feb 1;54(11):1280-1290. doi: 10.1039/c7cc09000e.
2
Ru(II) Polypyridyl Complexes Derived from Tetradentate Ancillary Ligands for Effective Photocaging.Ru(II) 金属卟啉配合物源于四齿辅助配体,可有效进行光笼闭。
Acc Chem Res. 2018 Jun 19;51(6):1415-1421. doi: 10.1021/acs.accounts.8b00066. Epub 2018 Jun 5.
3
Ruthenium(II) Polypyridyl-Based Photocages for an Anticancer Phytochemical Diallyl Sulfide: Comparative Dark and Photoreactivity Studies of Caged and Precursor Uncaged Complexes.基于钌(II)多吡啶的光笼用于抗癌植物化学物质二烯丙基硫醚:笼合物和前体无笼合物复合物的暗反应和光反应比较研究。
Inorg Chem. 2023 Nov 20;62(46):18839-18855. doi: 10.1021/acs.inorgchem.3c02038. Epub 2023 Nov 6.
4
Light activation of a cysteine protease inhibitor: caging of a peptidomimetic nitrile with Ru(II)(bpy)2.光激活半胱氨酸蛋白酶抑制剂:Ru(II)(bpy)2 笼蔽肽模拟物腈。
J Am Chem Soc. 2011 Nov 2;133(43):17164-7. doi: 10.1021/ja208084s. Epub 2011 Oct 12.
5
Mixed Ru(II)-Ir(III) Complexes as Photoactive Inhibitors of the Major Human Drug Metabolizing Enzyme CYP3A4.混合 Ru(II)-Ir(III) 配合物作为人源主要药物代谢酶 CYP3A4 的光活性抑制剂。
Inorg Chem. 2024 Oct 7;63(40):18509-18518. doi: 10.1021/acs.inorgchem.4c02633. Epub 2024 Sep 16.
6
Illuminating cytochrome P450 binding: Ru(ii)-caged inhibitors of CYP17A1.揭示细胞色素P450结合作用:CYP17A1的钌(II)笼形抑制剂
Chem Commun (Camb). 2017 Mar 28;53(26):3673-3676. doi: 10.1039/c7cc01459g.
7
Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.Ru(II) 金属卟啉配合物作为单光子和双光子光动力治疗光敏剂的应用的关键综述。
Acc Chem Res. 2017 Nov 21;50(11):2727-2736. doi: 10.1021/acs.accounts.7b00180. Epub 2017 Oct 23.
8
Solid-phase synthesis as a platform for the discovery of new ruthenium complexes for efficient release of photocaged ligands with visible light.作为发现新型钌配合物以实现光笼化配体可见光高效释放平台的固相合成。
Inorg Chem. 2015 Feb 16;54(4):1901-11. doi: 10.1021/ic502791y. Epub 2015 Jan 22.
9
Incorporation of Ru(II) Polypyridyl Complexes into Nanomaterials for Cancer Therapy and Diagnosis.将 Ru(II) 多吡啶配合物掺入纳米材料用于癌症治疗和诊断。
Adv Mater. 2020 Nov;32(47):e2003294. doi: 10.1002/adma.202003294. Epub 2020 Oct 19.
10
Tris-heteroleptic ruthenium(II) polypyridyl complexes: Synthesis, structural characterization, photophysical, electrochemistry and biological properties.三螯合钌(II)多吡啶配合物:合成、结构表征、光物理、电化学和生物性质。
J Inorg Biochem. 2020 Feb;203:110903. doi: 10.1016/j.jinorgbio.2019.110903. Epub 2019 Oct 21.

引用本文的文献

1
The Combination of Active-Targeted Photodynamic Therapy and Photoactivated Chemotherapy for Enhanced Cancer Treatment.主动靶向光动力疗法与光活化化疗联合用于增强癌症治疗
J Biophotonics. 2025 Jun;18(6):e70005. doi: 10.1002/jbio.70005. Epub 2025 Mar 14.
2
Control of metalloenzyme activity using photopharmacophores.利用光药理学基团控制金属酶活性
Coord Chem Rev. 2024 Jan 15;499. doi: 10.1016/j.ccr.2023.215485. Epub 2023 Oct 31.
3
Mixed Ru(II)-Ir(III) Complexes as Photoactive Inhibitors of the Major Human Drug Metabolizing Enzyme CYP3A4.混合 Ru(II)-Ir(III) 配合物作为人源主要药物代谢酶 CYP3A4 的光活性抑制剂。
Inorg Chem. 2024 Oct 7;63(40):18509-18518. doi: 10.1021/acs.inorgchem.4c02633. Epub 2024 Sep 16.
4
Ru(II) Oligothienyl Complexes with Fluorinated Ligands: Photophysical, Electrochemical, and Photobiological Properties.含氟配体的钌(II)低聚噻吩配合物:光物理、电化学和光生物学性质
Inorg Chem. 2024 May 27;63(21):9735-9752. doi: 10.1021/acs.inorgchem.3c04382. Epub 2024 May 10.
5
RuBi-Ruxolitinib: A Photoreleasable Antitumor JAK Inhibitor.鲁比鲁昔替尼:一种光释放的抗肿瘤 JAK 抑制剂。
J Am Chem Soc. 2024 May 15;146(19):13317-13325. doi: 10.1021/jacs.4c01720. Epub 2024 May 3.
6
Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents.基于 Ru(II) 菲咯啉的寡聚噻吩配合物作为光疗试剂。
Inorg Chem. 2023 Dec 25;62(51):21181-21200. doi: 10.1021/acs.inorgchem.3c03216. Epub 2023 Dec 11.
7
Tricolor visible wavelength-selective photodegradable hydrogel biomaterials.三色可见波长选择性光降解水凝胶生物材料。
Nat Commun. 2023 Aug 29;14(1):5250. doi: 10.1038/s41467-023-40805-w.
8
Ruthenium(II) Polypyridyl Complexes and Metronidazole Derivatives: A Powerful Combination in the Design of Photoresponsive Antibacterial Agents Effective under Hypoxic Conditions.钌(II)多吡啶配合物和甲硝唑衍生物:设计在缺氧条件下具有光响应抗菌活性的药物的有力组合。
Inorg Chem. 2023 May 22;62(20):7716-7727. doi: 10.1021/acs.inorgchem.3c00214. Epub 2023 May 10.
9
Turning Red without Feeling Embarrassed─Xanthenium-Based Photocages for Red-Light-Activated Phototherapeutics.无感脸红——用于红光激活光疗法的基于氧杂蒽的光笼
J Am Chem Soc. 2023 Feb 8;145(7):4026-34. doi: 10.1021/jacs.2c11499.
10
Not All MC States Are the Same: The Role of MC States in the Photochemical NN Ligand Release from [Ru(bpy)(NN)] Complexes.并非所有 MC 态都是相同的:MC 态在[Ru(bpy)(NN)]配合物的光化学 NN 配体释放中的作用。
Inorg Chem. 2022 Dec 12;61(49):19907-19924. doi: 10.1021/acs.inorgchem.2c03146. Epub 2022 Nov 30.

本文引用的文献

1
Combination of Ru(ii) complexes and light: new frontiers in cancer therapy.钌(II)配合物与光的联合:癌症治疗的新前沿
Chem Sci. 2015 May 1;6(5):2660-2686. doi: 10.1039/c4sc03759f. Epub 2015 Jan 13.
2
A Red-Light-Activated Ruthenium-Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells.一种红光激活的钌笼烟酰胺磷酸核糖转移酶抑制剂在缺氧癌细胞中仍具有光毒性。
Angew Chem Int Ed Engl. 2017 Sep 11;56(38):11549-11553. doi: 10.1002/anie.201703890. Epub 2017 Aug 9.
3
To cage or to be caged? The cytotoxic species in ruthenium-based photoactivated chemotherapy is not always the metal.该关起来还是被关起来?基于钌的光活化化疗中的细胞毒性物质并不总是金属。
Chem Commun (Camb). 2017 Jun 20;53(50):6768-6771. doi: 10.1039/c7cc03469e.
4
Combatting AMR: photoactivatable ruthenium(ii)-isoniazid complex exhibits rapid selective antimycobacterial activity.对抗抗生素耐药性:光可活化钌(II)-异烟肼复合物展现出快速的选择性抗分枝杆菌活性。
Chem Sci. 2017 Jan 1;8(1):395-404. doi: 10.1039/c6sc03028a. Epub 2016 Aug 30.
5
Illuminating cytochrome P450 binding: Ru(ii)-caged inhibitors of CYP17A1.揭示细胞色素P450结合作用:CYP17A1的钌(II)笼形抑制剂
Chem Commun (Camb). 2017 Mar 28;53(26):3673-3676. doi: 10.1039/c7cc01459g.
6
Ruthenium-containing P450 inhibitors for dual enzyme inhibition and DNA damage.含钌的 P450 抑制剂用于双重酶抑制和 DNA 损伤。
Dalton Trans. 2017 Feb 14;46(7):2165-2173. doi: 10.1039/c6dt04405k.
7
Caging the uncageable: using metal complex release for photochemical control over irreversible inhibition.囚禁不可囚禁之物:利用金属配合物释放实现对不可逆抑制的光化学控制
Chem Commun (Camb). 2016 Oct 18;52(85):12590-12593. doi: 10.1039/c6cc07083c.
8
Effects of Methyl Substitution in Ruthenium Tris(2-pyridylmethyl)amine Photocaging Groups for Nitriles.钌三(2-吡啶甲基)胺光解笼蔽基团中甲基取代对腈的影响。
Inorg Chem. 2016 Jul 18;55(14):6968-79. doi: 10.1021/acs.inorgchem.6b00650. Epub 2016 Jun 29.
9
Pivotal Role of a Pentacoordinate (3)MC State on the Photocleavage Efficiency of a Thioether Ligand in Ruthenium(II) Complexes: A Theoretical Mechanistic Study.五配位(3)MC态在钌(II)配合物中硫醚配体光解效率上的关键作用:一项理论机理研究
Inorg Chem. 2016 May 2;55(9):4448-56. doi: 10.1021/acs.inorgchem.6b00268. Epub 2016 Apr 7.
10
Calcium Uncaging with Visible Light.可见光介导的钙释放
J Am Chem Soc. 2016 Mar 23;138(11):3687-93. doi: 10.1021/jacs.5b11606. Epub 2016 Mar 14.